National Research Corp (NRC) - Cash Flow Conversion Efficiency

Latest as of June 2026: 0.212x

Based on the latest financial reports, National Research Corp (NRC) has a cash flow conversion efficiency ratio of 0.212x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($1.39 Million) by net assets ($6.55 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of National Research Corp for the company's overall valuation and market capitalisation.

National Research Corp - Cash Flow Conversion Efficiency Trend (1996–2025)

This chart illustrates how National Research Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data.

National Research Corp Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of National Research Corp ranked by their cash flow conversion efficiency. Explore NRC cash to earnings ratio to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
MPS Limited
NSE:MPSLTD
0.176x
China Bicycle Co Holdings Ltd
SHE:000017
-0.041x
GULF KEYSTONE PETR.
F:GVP1
N/A
Titan International Inc
NYSE:TWI
0.077x
YeaShin International Development Co Ltd
TWO:5213
-0.145x
Nextensa NV
BR:NEXTA
0.030x
Shengjing Bank Co. Ltd
F:6SY
-0.295x
Digital Network S.A.
WAR:DIG
0.143x

Annual Cash Flow Conversion Efficiency for National Research Corp (1996–2025)

The table below shows the annual cash flow conversion efficiency of National Research Corp from 1996 to 2025. View National Research Corp (NRC) share price today for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 $13.99 Million $26.45 Million 1.891x +70.82%
2024-12-31 $31.28 Million $34.62 Million 1.107x +42.16%
2023-12-31 $48.95 Million $38.11 Million 0.779x +54.64%
2022-12-31 $72.03 Million $36.27 Million 0.503x -7.30%
2021-12-31 $85.34 Million $46.34 Million 0.543x -14.05%
2020-12-31 $64.31 Million $40.64 Million 0.632x -49.21%
2019-12-31 $32.89 Million $40.92 Million 1.244x -40.43%
2018-12-31 $19.08 Million $39.85 Million 2.088x +569.32%
2017-12-31 $90.04 Million $28.09 Million 0.312x -3.76%
2016-12-31 $82.81 Million $26.84 Million 0.324x +9.93%
2015-12-31 $74.22 Million $21.89 Million 0.295x -1.23%
2014-12-31 $87.75 Million $26.20 Million 0.299x +10.91%
2013-12-31 $71.75 Million $19.32 Million 0.269x -20.17%
2012-12-31 $56.74 Million $19.13 Million 0.337x +1.36%
2011-12-31 $55.55 Million $18.48 Million 0.333x +10.68%
2010-12-31 $48.58 Million $14.60 Million 0.301x -2.85%
2009-12-31 $44.17 Million $13.67 Million 0.309x -21.31%
2008-12-31 $38.60 Million $15.18 Million 0.393x +14.14%
2007-12-31 $42.29 Million $14.57 Million 0.344x +85.83%
2006-12-31 $36.75 Million $6.81 Million 0.185x -26.21%
2005-12-31 $32.59 Million $8.19 Million 0.251x +12.54%
2004-12-31 $35.02 Million $7.82 Million 0.223x -12.43%
2003-12-31 $32.42 Million $8.27 Million 0.255x +66.71%
2002-12-31 $28.02 Million $4.28 Million 0.153x +15.95%
2001-12-31 $23.35 Million $3.08 Million 0.132x +39.36%
2000-12-31 $21.38 Million $2.02 Million 0.095x -49.71%
1999-12-31 $18.60 Million $3.50 Million 0.188x -18.15%
1998-12-31 $17.40 Million $4.00 Million 0.230x +177.39%
1997-12-31 $18.10 Million $1.50 Million 0.083x -97.24%
1996-12-31 $2.10 Million $6.30 Million 3.000x --

About National Research Corp

NASDAQ:NRC USA Health Information Services
Market Cap
$486.18 Million
Market Cap Rank
#12701 Global
#3149 in USA
Share Price
$21.96
Change (1 day)
-1.57%
52-Week Range
$11.42 - $22.77
All Time High
$64.76
About

NRC Health provides analytics and insights to measure and improve patient and employee experience for healthcare organizations in the United States. The company offers market experience solutions, a subscription-based services for improved tracking of awareness, perception, and consistency of healthcare brands; assessment of differentiators; and segmentation tools to evaluate the needs, wants, an… Read more